Press Release

visiongain

Antibacterial Drugs: World Market Prospects 2023

February 22nd, 2021 5:10 PM

Discover new trends, opportunities and revenue prospects for bacteria-killing medicines
Where’s the antibiotics market heading? How are those products performing? Visiongain’s updated report gives you forecasted revenues there to 2023 and also explains R&D trends, outlooks and commercial opportunities.

Our study lets you assess sales data and predictions for the world antibacterial drugs market, therapeutic submarkets, important products and national markets. Those analyses show you that pharmaceutical field’s most promising and lucrative segments.

Established and emerging bacteria-treating technologies have potential. Read on to scan features of that industry, find what drives it, and see what its future market could be worth.

Forecasts and other analyses to help you stay ahead in knowledge

That report gives you revenue forecasts to 2023, historical data, growth rates and market shares. It lets you discover quantitative and qualitative analysis, business outlooks and developmental trends (R&D). You gain 113 tables, 86 charts and two research interviews.

Is finding commercial data a challenge? With our study you can stay ahead in knowledge, benefiting your research, analyses and decisions. There you find trends, innovations and opportunities for human medicine. You see what’s happening, discovering possibilities.

There is rising need worldwide for drugs to treat bacterial infections. For those agents, our work helps you find business areas that will prosper, reducing the risk of your missing out.

The following sections show how you benefit from our new study of that antimicrobials field.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market for treating bacterial infections in human beings, you see forecasts to 2023 for these six submarkets:
• Cephalosporins
• Penicillins
• Fluoroquinolones
• Macrolides
• Carbapenems
• Other agents.

Our work shows you overall commercial prospects for generic and novel antibiotics.

Do you understand the changing market, knowledge needed to achieve maximum sales? Our report helps you identify potential and find opportunities for your business to prosper.

Likewise, our investigation discusses what stimulates and restrains business. In that work you find dynamics of the industry and assess its potential sales, seeing what drugs are likely to achieve the most success.

See revenue forecasts for 26 leading drugs

How will leading antibiotics perform to 2023 at world level? Our study forecasts sales of 26 products, including these brands:
• Augmentin
• Zyvox
• Avelox
• Cubicin
• Zosyn
• Cravit/Levaquin
• Merrem/Meropen
• Biaxin/Clarith
• Primaxin.

There you discover how high sales can go, to 2023, finding areas and years with highest predicted revenues and growth. Also, find how competitors compare – assess competition. You see what’s happening, understanding trends, challenges and opportunities.

That study also divides its overall world revenue forecast into those for the main geographical markets.

What prospects for leading regions and countries?

In developed and developing countries – especially India and China – there are still many opportunities for developing, manufacturing and selling drugs to treat bacterial infections. You see opportunities for producers and sellers of those antimicrobial medicines.

Our analyses show you individual revenue forecasts to 2023 for eleven national markets and one regional block:
• US
• Japan
• Germany, France, UK, Italy and Spain (EU5) and a forecast for the EU
• Brazil, Russia, India and China (BRIC).

There you discover progress and outlooks. That way you assess the industry’s future – hear about developments and find their significance.

Our forecasting shows revenue growth will occur in established pharma markets and in developing countries. In particular, antibiotic product launches from 2013 to 2023 will change medical prescribing and the commercial landscape.

Research and development – assess innovation, trends and possibilities

What about R&D – the pipeline for new drugs? You see developmental trends for these agents and others:
• Small molecule therapies
• Cephalosporins
• Oxazolidinones
• ß-Lactamase inhibition
• Macrolides
• Inhaled antibiotics
• MRSA-specific treatments.

In our work you assess innovations, hearing about developments and finding their significance. Discover progress.

See, then, what the future holds. For large companies and specialty pharma firms there exist many opportunities. Our study explains, discussing many issues.

What affects that antimicrobials field?

Our report discusses issues and events affecting that industry and market from 2013:
• Regulatory approvals and expanded indications
• Growth in emerging national and therapeutic markets
• Antibacterial drug resistance and restricting antibiotic use
• Challenge and opportunity in treating hospital-acquired infections (HAIs)
• Developments in antibacterial diagnostics
• Generic drugs and their competition to novel brands – patent challenges and expiries
• Combination therapy to aid product lifecycle management.

The work also discusses these aspects of the antibacterials field:
• Opportunities for biotechs, including developing of biological drug therapies
• Genomics in antibacterial drug development
• Public funding for research and antibiotic development
• Concerns over safety and marketing
• Oxazolidinone product launches with potential to invigorate the market
• Activity against MRSA stimulating revenue growth.

That way, you explore technological, economic, social and political (STEP) questions, assessing outlooks for that area of business.

Press Release

  • Recent
  • Popular
  • Comments
  • Energy Harvesting Equipment Industry 2026 : Detailed survey of the key competitors and the leading players

    Learn More
  • Electric Vehicles (EV) Industry Detailed Analytical Overview by 2026

    Learn More
  • Electric Two-Wheeler Industry : Future Demand, Industry Analysis & Outlook to 2026

    Learn More
  • Medical Tricorder Market 2020 Analysis Trend, Applications, Industry Chain Structure, Growth, and Forecast

    Learn More
  • Opioid Market Development Trends, Revenue and In-Depth Analysis with Specifications

    Learn More
  • Glaucoma Market Business Strategy and Industry Segments Poised for Strong Growth in Future 2028

    Learn More
  • Medical Tricorder Market 2020 Analysis Trend, Applications, Industry Chain Structure, Growth, and Forecast

    Learn More
  • Energy Harvesting Equipment Industry 2026 : Detailed survey of the key competitors and the leading players

    Learn More